Vera Therapeutics, Inc. (NASDAQ:VERA) Receives $65.00 Average PT from Analysts
Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) has received an average recommendation of “Buy” from the ten analysts that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a hold rating, seven have assigned a buy rating and two have issued a strong buy rating on the company. […]
Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) has received an average recommendation of “Buy” from the ten analysts that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a hold rating, seven have assigned a buy rating and two have issued a strong buy rating on the company. […]
